• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    Just unveiled: Tuberculosis vaccine research blueprint

    By Ivy Mungcal // 20 March 2012
    Apparatus for BCG vaccination used in Japan and Ireland. Photo by: Y tambe / CC BY-SA

    A new roadmap outlining key priorities for tuberculosis vaccine research and development for the next 10 years is now available.

    The blueprint, which was published March 20 in the journal Tuberculosis, was endorsed and sponsored by the World Health Organization-led Stop TB Partnership Working Group on New Vaccines. It is designed to inform donors, the public and affected stakeholders that “there is now a global effort to do something about this terrible disease,” SciDev.Net says.

    The blueprint identifies five priorities for the tuberculosis vaccine research community: enable creativity in research, achieve a better understanding of the infectious disease, improve coordination of late-stage clinical trials, develop quicker and more innovative ways to test vaccine efficacy, and promote more rapid development.

    Further, the roadmap proposes the creation of global criteria for choosing the best vaccine candidates and calls for greater advocacy and media engagement to build political support for research and development.

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Ivy Mungcal

      Ivy Mungcal

      As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.

    Search for articles

    Related Jobs

    • Individual Consultant: Hospital Planner
      Ulan Bator, Mongolia | Mongolia | East Asia and Pacific
    • Individual Consultant: Health Service Needs Assessment Consultant
      Mongolia | East Asia and Pacific
    • Director Advocacy and Strategic Partnerships
      Nairobi, Kenya | Kenya | Eastern Africa
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      How low-emissions livestock are transforming dairy farming in Africa
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      Strengthening health systems by measuring what really matters
    • 5
      How AI-powered citizen science can be a catalyst for the SDGs

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global healthHow Trump’s aid freeze is threatening tuberculosis programs

    How Trump’s aid freeze is threatening tuberculosis programs

    Global HealthStop TB Partnership retains US funds but must revise scope, cut staff

    Stop TB Partnership retains US funds but must revise scope, cut staff

    Talking TB: Sponsored by Stop TB PartnershipOpinion: India’s bold leadership in turning the tide for TB

    Opinion: India’s bold leadership in turning the tide for TB

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement